{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T09:10:09Z","timestamp":1740906609863,"version":"3.38.0"},"reference-count":14,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:p> An audit of 72 patients presenting for post-exposure prophylaxis following sexual exposure (PEPSE) to HIV (68 genitourinary medicine and 4 accident &amp; emergency) was conducted from 2003 to 2009. The principal indications for PEPSE included 27 (38%) unprotected intercourse (15\/27 vaginal and 12\/27 anal) with a known HIV-positive partner, 20 (28%) unprotected receptive anal sex with male partner of unknown status, 17 (24%) following sexual assault and three (4%) unprotected sex with a partner from an endemic country. Of those who commenced PEPSE, 92% did so within the recommended 72 hours. Concurrent sexually transmitted infection (STI) was diagnosed in 8.3% patients (6.9% non-gonococcal urethritis and 1.4% rectal chlamydia). Fifty (69%) patients attended for follow-up and only 8% of these did not complete treatment. Twenty-five (35%) patients attended for repeat serology at three months and 18 (25%) at six months. All of the patients followed up remained HIV-negative. <\/jats:p>","DOI":"10.1258\/ijsa.2009.009463","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T09:33:06Z","timestamp":1309858386000},"page":"407-408","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Post-exposure prophylaxis following sexual exposure to HIV: a seven-year retrospective analysis in a regional centre"],"prefix":"10.1177","volume":"22","author":[{"given":"E J","family":"McCarty","sequence":"first","affiliation":[{"name":"Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Quah","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Maw","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W W","family":"Dinsmore","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Emerson","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C1","DOI":"10.1097\/00126334-200404150-00010"},{"unstructured":"SchecterM. Occupational and sexual PEP \u2013 benefit\/risk? 6th International Conference on Drug Therapy in HIV Infection 2002. Glasgow, UK (abst. PL 6.1)","key":"bibr-IJSA-09-463C2"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C3","DOI":"10.1056\/NEJM199711203372101"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C4","DOI":"10.1056\/NEJM199811123392001"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C5","DOI":"10.1258\/ijsa.2007.007252"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C6","DOI":"10.1128\/JVI.72.5.4265-4273.1998"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C7","DOI":"10.1128\/JVI.74.20.9771-9775.2000"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C8","DOI":"10.1258\/095646206775455829"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C9","DOI":"10.1136\/sti.2005.014886"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C10","DOI":"10.1097\/00002030-200403260-00010"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C11","DOI":"10.1097\/00126334-200404150-00010"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C12","DOI":"10.1080\/09540120701660353"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C13","DOI":"10.1136\/sti.2005.014662"},{"doi-asserted-by":"publisher","key":"bibr-IJSA-09-463C14","DOI":"10.1097\/QAI.0b013e318162afcb"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/ijsa.2009.009463","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1258\/ijsa.2009.009463","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/ijsa.2009.009463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T07:59:26Z","timestamp":1740902366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1258\/ijsa.2009.009463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1258\/ijsa.2009.009463"],"URL":"https:\/\/doi.org\/10.1258\/ijsa.2009.009463","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"type":"print","value":"0956-4624"},{"type":"electronic","value":"1758-1052"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}